M. Norman

Plasminogen activators in human breast cancer cell lines: hormonal regulation and properties.

B. Katzenellenbogen, A. Nardulli, W. Mangel, 1988, Journal of steroid biochemistry.

Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.

B. Katzenellenbogen, J. Katzenellenbogen, K. Carlson, 1987, Journal of medicinal chemistry.

Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

B. Katzenellenbogen, S. Peltz, W. Mangel, 1984, Cancer research.

Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.

B. Katzenellenbogen, M. Norman, 1990, Endocrinology.

Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome

D. Malkin, R. Kim, Y. Sundaravadanam, 2022, medRxiv.

in the Short-Term and Long-Term Absence of Estrogens Receptor Content of MCF-7 Human Breast Cancer Cells Grown Proliferation , Hormonal Responsiveness , and Estrogen Updated

B. Katzenellenbogen, Y. Berthois, M. Norman, 2006 .

Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.

B. Katzenellenbogen, Y Berthois, B S Katzenellenbogen, 1987, Cancer research.

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

R Clarke, B. Katzenellenbogen, R. Clarke, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells.

P. Newcomb, C. Perks, C M Perks, 1999, Journal of molecular endocrinology.